No Detail Found!

Plasma ApoA-1 and endothelin-1 levels changes in early Parkinson disease and its relationship with cognitive function and cerebral white matter structure change

Author(s)
Yingying Yan Department of Neurology, Yinzhou Second Hospital of Ningbo City,Zhejiang Province,China
Jianjiong Fu Department of Neurology, Zhuji Affiliated Hospital of Shaoxing University,Zhejiang Province,China
Abstract
The study aimed to investigate the plasma apolipoprotein A-1 (ApoA-1) and endothelin -1 (ET-1) changes in early Parkinson disease (PD), and analyze their relationship with cognitive function and cerebral white matter structure (WMS) change. 76 early PD patients were selected as group PD, and 30 cases of healthy persons were selected as control group. They all scanned with magnetic resonance imaging (MRI) diffusion tensor. The ApoA-1, ET-1, WMS changes, and Montreal Cognitive Assessment (MoCA) scores were recorded in the two groups of subjects. The results revealed that ApoA-1 level and Mo CA score in PD group decreased, FA value in bilateral temporal lobe, left anterior cingulate tract, corpus callosum, and other cerebral WMS area in PD group were also decreased, and ET-1 level in PD group increased (P<0.05). Compared with those of PD group patients with Mo CA=26, plasma ApoA-1 levels and cerebral WMS FA values of the patients with Mo CA<26 were decreased, (P<0.05); the MoCA score of PD group was positively correlated with the cerebral WMS FA values (P<0.05). In short, the ApoA-1 level in patients with early PD decreased, while the ET-1 level increased, and both were related to cognitive function and WMS.
Publication Details
Page(s) 487-492
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 34, Issue: S1, Year: 2021

Request the full text from PASTIC

Keywords
cerebral white matter structure, apolipoprotein A-1, Endothelin-1, Cognitive function, Parkinson Disease
References
Arrigo A,Calamuneri A,Milardi D,Mormina E,Rania L,Postorino E,Marino S,Di Lorenzo G,Anastasi GP,Ghilardi MF,Aragona P,Quartarone A,Gaeta M .2017 .Visual system involvement in patients with newly diagnosed Parkinson's disease. Radiology, 285(3) : 885-895.
Bledsoe IO,Stebbins GT,Merkitch D,Goldman JG .2018 .White matter abnormalities in the corpus callosum with cognitive impairment in Parkinson disease. Neurology, 91(24) : e2244-e2255.
Costa-Mallen P,Gatenby C,Friend S,Maravilla KR,Hu SC,Cain KC,Agarwal P,Anzai Y .2017 .Brain iron concentrations in regions of interest and relation with serum iron levels in Parkinson's disease. J. Neurol. Sci., 378 : 38-44.
Dadar M,Zeighami Y,Yau Y,Fereshtehnejad SM,Maranzano J,Postuma RB,Dagher A,Collins DL .2018 .White matter hyperintensities are linked to future cognitive decline in de novo Parkinson's disease patients. Neuroimage Clin., 20 : 892-900.
Ji GJ,Ren C,Li Y,Sun J,Liu T,Gao Y,Xue D,Shen L,Cheng W,Zhu C,Tian Y,Hu P,Chen X,Wang K X .2019 .Regional and network properties of white matter function in Parkinson's disease. Hum. Brain Mapp, 40(4) : 1253-1263.
Ly H,Verma N,Wu F,Liu M,Saatman KE,Nelson PT,Slevin JT,Goldstein LB,Biessels GJ,Despa F GJ .2017 .Brain microvascular injury and white matter disease provoked by diabetes-associated hyperamylinemia. , 82(2) : 208-222.
Malak ALSB,Vasconcellos LF,Pereira JS,Greca DV,Cruz M,Alves HVD,Sptiz M,CharchatFichman H M .2017 .Symptoms of depression in patients with mild cognitive impairment in Parkinson's disease. Dement Neuropsychol, 11(2) : 145-153.
Rektor I,Svátková A,Vojtíšek L,Zikmundová I,Vaníček J,Király A,Szabó N A .2018 .White matter alterations in Parkinson's disease with normal cognition precede grey matter atrophy. PLoS One, 13(1) : e0187939.
Sterling NW,Du G,Lewis MM,Swavely S,Kong L,Styner M,Huang X .2017 .Cortical gray and subcortical white matter associations in Parkinson's disease. Neurobiol. Aging, 49 : 100-108.
Ten Harmsen BL,van Rumund A,Aerts MB,Bergkamp MI,Esselink RAJ,Richard E,Meijer FJA,Bloem BR .2018 .Clinical correlates of cerebral white matter abnormalities in patients with Parkinson's disease. Parkinsonism Relat, 49 : 28-33.
Wang X,Li R,Zacharek A,Landschoot-Ward J,Chopp M,Chen J,Cui X .2019 .ApoA-I mimetic peptide reduces vascular and white matter damage after stroke in type-2 diabetic mice. Front Neurosci., 13 : 1127.
Winer JR,Maass A,Pressman P,Stiver J,Schonhaut DR,Baker SL,Kramer J,Rabinovici GD,Jagust WJ,Amyloid WJ .2018 .and cognition in parkinson disease. JAMA Neurol, 75(2) : 227-235.
Yau Y,Zeighami Y,Baker TE,Larcher K,Vainik U,Dadar M,Fonov VS,Hagmann P,Griffa A,Mišić B,Collins DL,Dagher A .2018 .Network connectivity determines cortical thinning in early Parkinson's disease progression. Nat. Commun, 9(1) : 12.
0

Citations

0

Downloads

10

Views